These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8886214

  • 1. Clinical efficacy and safety of Naprelan versus Naprosyn in the treatment of rheumatoid arthritis.
    Lisse JR.
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):21-9. PubMed ID: 8886214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, parallel-group study of the pharmacokinetics and onset of action of Naprelan in patients following oral surgery.
    Gaston G.
    Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):37-41. PubMed ID: 8886216
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S.
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [Abstract] [Full Text] [Related]

  • 6. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A, Eisen G, Zhao WW, Bevirt T, Recker DP.
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [Abstract] [Full Text] [Related]

  • 7. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW, Kivitz AJ, Brown MT, Verburg KM.
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [Abstract] [Full Text] [Related]

  • 8. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
    Fleischmann RM, Flint K, Constantine G, Kolecki B.
    Clin Ther; 1997 Feb; 19(4):642-55. PubMed ID: 9377610
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 10. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR, Benson GD, Zinsenheim JR, Schweinle JE.
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [Abstract] [Full Text] [Related]

  • 11. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L, Goldstein JL, Vu A, Mayne TJ, Rublee DA.
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [Abstract] [Full Text] [Related]

  • 12. Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
    Kolodny AL.
    J Rheumatol; 1988 Aug; 15(8):1205-11. PubMed ID: 3054094
    [Abstract] [Full Text] [Related]

  • 13. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
    Caldwell JR, Roth SH.
    J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 15. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
    Schnitzer TJ, Kamin M, Olson WH.
    Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
    [Abstract] [Full Text] [Related]

  • 16. Diflunisal versus naproxen in the management of rheumatoid arthritis.
    Osborn TG, Parks RL, Moore TL, Grisanti MW, Nesher G, Caciolo BA.
    Clin Ther; 1989 Jul; 11(6):736-43. PubMed ID: 2692819
    [Abstract] [Full Text] [Related]

  • 17. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ.
    Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
    [Abstract] [Full Text] [Related]

  • 18. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR.
    Clin Ther; 1994 Sep; 16(2):222-35. PubMed ID: 8062318
    [Abstract] [Full Text] [Related]

  • 20. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
    Pavelka K, Recker DP, Verburg KM.
    Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.